Wolverine Trading’s Seres Therapeutics MCRB Stock Holding History

Wolverine Trading’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-690	Closed	-$11.5K	–	5411
2024 Q4	$11.5K	Sell	690 -910	-57%	-$14.8K	﹤0.01%	5149
2024 Q3	$29.4K	Buy	+1,600	New	+$32.5K	﹤0.01%	4598
2024 Q2	–	Sell	-730	Closed	-$11.3K	–	4937
2024 Q1	$11.3K	Buy	+730	New	+$15.7K	﹤0.01%	4365
2023 Q3	–	Sell	-565	Closed	-$53K	–	4843
2023 Q2	$53K	Buy	+565	New	+$61.5K	﹤0.01%	3932
2021 Q4	–	Sell	-580	Closed	-$79K	–	6455
2021 Q3	$79K	Sell	580 -410	-41%	-$80.2K	﹤0.01%	5885
2021 Q2	$473K	Buy	990 +490	+98%	+$207K	﹤0.01%	3783
2021 Q1	$194K	Sell	500 -185	-27%	-$85.2K	﹤0.01%	5073
2020 Q4	$360K	Buy	685 +55	+9%	+$32.2K	﹤0.01%	3542
2020 Q3	$362K	Buy	+630	New	+$210K	﹤0.01%	3160
2019 Q1	–	Sell	-665	Closed	-$64K	–	4974
2018 Q4	$64K	Buy	+665	New	+$93.1K	﹤0.01%	4111

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Wolverine Trading's MCRB Position: Q4 2024 in Review

Wolverine Trading sold out of Seres Therapeutics (MCRB) in Q4 2024, closing a stake of 1,107 shares — an estimated $18K sold.

Wolverine Trading first reported a position in MCRB in Q4 2020 and held it in 8 quarters. The position peaked at $413K in Q1 2021. 69 funds tracked by Wall St. Rank hold MCRB as of Q4 2024.

Wolverine Trading reported no remaining Seres Therapeutics position as of Q4 2024 after selling out during the quarter.
Wolverine Trading sold 1,107 Seres Therapeutics shares in Q4 2024, an estimated $18K.
Wolverine Trading first reported a position in Seres Therapeutics in Q4 2020 and held it in 8 quarters.
Wolverine Trading's Seres Therapeutics position peaked at $413K in Q1 2021.
69 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.